BioCentury
ARTICLE | Company News

Provalis acquires PFE drugs in U.K.

October 25, 2001 7:00 AM UTC

Provalis (LSE:PRO) acquired the U.K. marketing rights and stocks of Diclomax Retard and Diclomax SR anti-inflammatory drugs from Parke-Davis, a subsidiary of Pfizer (PFE), for L15.3 million ($22 milli...